Munafa Stock Market Course + Intraday & FNO calls 
RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY
Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Dr. Reddy's Laboratories Ltd RDY
Dr Reddy's Labs Q2 Preview: Healthy double-digit revenue growth seen, but PAT may fall
For the July-September 2024 period, net profit is expected to decline by 3% year-on-year, based on the average estimate from four brokerages. Sales, however, are projected to increase by 13% year-on-year, according to the estimates.
Announcement as on 04 November 2024
Dr Reddy's recalls over 3.3 lakh bottles of generic medication in US: USFDA
Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets in the US due to manufacturing issues. The recall is due to the presence of an impurity above FDA limits. The recall affects 30 mg, 60 mg, and 90 mg strengths, with the affect
Announcement as on 03 November 2024
Dr Reddy's launches medication to treat chronic constipation
Dr Reddy's Laboratories has launched BixiBat, a new drug for chronic constipation in India. It is the first company to receive approval from the CDSCO for Elobixibat. The drug works by increasing bile acid concentration in the colon, promoting bowel moveme
Announcement as on 28 October 2024
Dr Reddy's enters voluntary licensing deal with Gilead for long-acting HIV drug
Dr. Reddy’s has partnered with Gilead Sciences to manufacture and market the HIV drug Lenacapavir in India and 120 other countries. The agreement includes developing Lenacapavir for both treatment and potential prevention of HIV. This collaboration aims
Announcement as on 02 October 2024
Dr Reddy's ties up with Gilead to manufacture, commercialise HIV drug
Dr Reddy's Laboratories on Wednesday said it has tied up with Gilead Sciences for the manufacture and commercialisation of the HIV drug Lenacapavir in India and 120 other countries. The company has entered into a royalty-free non-exclusive voluntary licens
Announcement as on 02 October 2024
Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |
RDY Dr. Reddy's Laboratories Ltd current price & indicator signals
Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 29 Mon Jun 2026 | 14.86 | 14.66 to 15.13 | -3.38% | 1.93 times |
| 26 Fri Jun 2026 | 15.38 | 15.30 to 15.67 | 0.85% | 1.34 times |
| 25 Thu Jun 2026 | 15.25 | 14.61 to 15.27 | 4.02% | 1.68 times |
| 24 Wed Jun 2026 | 14.66 | 14.20 to 14.66 | 2.45% | 1.13 times |
| 23 Tue Jun 2026 | 14.31 | 13.80 to 14.31 | 2.88% | 1.51 times |
| 22 Mon Jun 2026 | 13.91 | 13.45 to 14.03 | 4.67% | 1.17 times |
| 18 Thu Jun 2026 | 13.29 | 13.20 to 13.36 | 1.06% | 0.73 times |
| 17 Wed Jun 2026 | 13.15 | 13.08 to 13.32 | -1.13% | 1.05 times |
| 16 Tue Jun 2026 | 13.30 | 13.23 to 13.38 | -0.23% | 0.59 times |
| 15 Mon Jun 2026 | 13.33 | 13.32 to 13.43 | 0.23% | 0.37 times |
| 12 Fri Jun 2026 | 13.30 | 13.30 to 13.40 | -0.45% | 0.43 times |
| 11 Thu Jun 2026 | 13.36 | 13.11 to 13.40 | 0.45% | 0.43 times |
Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
